What Is GHK-Cu?
GHK-Cu (Glycine-Histidine-Lysine copper complex) is a naturally occurring tripeptide-copper complex found in human plasma, saliva, and urine. It was first isolated from human plasma albumin in 1973 by Loren Pickart, who discovered that it stimulated liver cell growth in culture. Decades of subsequent research revealed that GHK-Cu is far more than a growth factor — it is a master regulator of tissue repair and gene expression that acts across hundreds of biological pathways simultaneously. Its plasma concentration declines significantly with age, from approximately 200 ng/mL in young adults to 80 ng/mL by the sixth decade, positioning it as a research compound of significant interest in aging biology.
All products sold by FenaLife are intended strictly for laboratory and academic research purposes. Not for human consumption, injection, or ingestion. These statements have not been evaluated by the FDA.
Molecular Profile
| Property | Value |
|---|---|
| Full name | Glycine-L-Histidine-L-Lysine copper(II) complex |
| Sequence | Gly-His-Lys |
| Length | 3 amino acids (tripeptide) |
| Molecular weight | ~403 Da (free peptide); ~467 Da (copper complex) |
| Origin | Endogenous — derived from collagen degradation and plasma albumin N-terminus |
| Discovery | Loren Pickart, 1973 |
| Endogenous plasma level (young adult) | ~200 ng/mL |
| Endogenous plasma level (60+ years) | ~80 ng/mL |
| Half-life (plasma) | ~0.5–2 hours |
| Colour in solution | Blue-green (copper complex) |
Mechanism of Action
Copper Transport and Delivery
GHK-Cu’s primary structural role is as a high-affinity copper(II) chaperone. Copper is an essential trace element required for multiple enzymatic processes, but free copper is toxic. GHK binds copper with high affinity and delivers it safely to copper-dependent enzymes including lysyl oxidase (collagen and elastin crosslinking), superoxide dismutase (antioxidant defence), cytochrome c oxidase (Complex IV of the mitochondrial ETC), and ceruloplasmin (iron metabolism). This targeted copper delivery is one mechanism by which GHK-Cu stimulates collagen synthesis and antioxidant activity.
Gene Expression Regulation — ~4,000 Genes
Beyond copper delivery, GHK-Cu is one of the most potent known regulators of gene expression for a compound of its small size. Microarray studies have shown that GHK-Cu modulates the expression of approximately 4,000 human genes — roughly 31% of the human genome’s protein-coding genes. The pattern is consistent: it upregulates genes involved in tissue repair, collagen synthesis, anti-inflammatory signalling, antioxidant defence, and stem cell mobilisation, while downregulating genes associated with inflammation, oxidative stress, tumour progression, and tissue destruction. This broad gene expression effect is mediated through multiple transcription factor pathways including SP1, AP1, and NF-κB.
Fibroblast and Wound Healing Biology
In wound healing models, GHK-Cu acts as a chemoattractant for immune cells and fibroblasts, recruiting them to the wound site. It promotes fibroblast proliferation, migration, and collagen synthesis, stimulates angiogenesis through multiple growth factor pathways, and upregulates decorin (a proteoglycan that organises collagen fibre architecture). The combination of cellular recruitment, collagen synthesis, and vascular formation covers most of the key processes in the proliferative phase of wound healing.
Key Research Areas
Skin and Dermal Research
GHK-Cu’s most extensively studied application is dermal — skin thickening, collagen synthesis, wrinkle reduction, and wound healing in both preclinical models and some human studies. Key findings include:
- Increased dermal collagen by 70% in aged skin in some studies
- Stimulation of elastin and glycosaminoglycan synthesis
- Reduced expression of matrix metalloproteinases (MMPs) that degrade collagen
- Upregulation of decorin, improving collagen fibre organisation
- Stimulation of hair follicle enlargement and follicle size in some models
These findings form the scientific basis for GHK-Cu’s widespread use in cosmetic and dermatological research formulations.
Wound Healing
Animal wound healing studies consistently show accelerated wound closure with GHK-Cu administration. The compound promotes all three phases of wound healing: it reduces inflammation in the inflammatory phase, accelerates fibroblast proliferation and collagen deposition in the proliferative phase, and organises collagen architecture in the remodelling phase. Human wound healing studies, while limited in number, show trends toward improved healing in chronic wound models.
Anti-Aging Gene Expression
Analysis of GHK-Cu’s gene expression signature shows substantial overlap with pathways implicated in longevity research. GHK-Cu upregulates genes in the ubiquitin-proteasome pathway (protein quality control), suppresses pathways associated with chronic inflammation (the “inflammaging” phenotype of aging), and downregulates several genes overexpressed in age-related cancers. Loren Pickart’s later research proposed that declining GHK plasma levels with age represent a partial explanation for the progressive impairment of tissue maintenance and repair seen in aging.
Hair Growth Research
GHK-Cu stimulates hair follicle enlargement and prolongs the anagen (growth) phase of the hair cycle in rodent and some human studies. It upregulates vascular endothelial growth factor (VEGF) in the scalp, improving follicle blood supply, and has been incorporated into topical hair loss research formulations.
Nerve Regeneration
Emerging research shows GHK-Cu promotes nerve growth factor (NGF) synthesis and may support peripheral nerve repair. In vitro studies demonstrate enhanced neurite outgrowth. This area is less developed than the wound healing and skin data but represents an active research direction.
Antioxidant Research
GHK-Cu upregulates superoxide dismutase (SOD) via copper delivery and transcriptional mechanisms, enhancing cellular antioxidant capacity. It also suppresses oxidative stress gene expression pathways identified in lung tissue research, where it has shown anti-fibrotic effects in pulmonary fibrosis models.
Comparison with Other Repair Peptides
See the GHK-Cu vs BPC-157 comparison for a detailed head-to-head analysis. In brief: GHK-Cu leads for dermal, collagen, and gene expression research; BPC-157 leads for musculoskeletal, gastrointestinal, and neurological repair research. Their mechanisms are complementary and both are included in the KLOW/GLOW research blends.
Storage and Handling
| Parameter | Specification |
|---|---|
| Lyophilised storage | −20°C, protect from light |
| Reconstitution solvent | Bacteriostatic water |
| Post-reconstitution storage | 2–8°C, use within 28 days |
| Freeze-thaw (reconstituted) | Avoid |
| Light sensitivity | High — copper complex is photosensitive |
| Colour in solution | Blue-green — normal for GHK-Cu complex |
| Special notes | Use amber vials or wrap in foil during storage |
Frequently Asked Questions
Is GHK-Cu safe for topical use in research?
GHK-Cu has an extensive safety record in cosmetic and dermatological research applications. It is endogenous — the body produces it naturally — and it has not shown toxicity in published research at typical research concentrations. Topical application is the most studied route for skin research. Injectable use requires sterile preparation and all standard research compound handling protocols.
Why is GHK-Cu blue-green in solution?
The blue-green colour comes from the copper(II) ion complexed with the peptide. Copper(II) absorbs light in the orange-red range, producing the characteristic blue-green appearance. This colour is normal and expected — it is not a sign of degradation. If the solution becomes colourless after storage, it may indicate that the copper has dissociated from the peptide.
What is the relationship between GHK-Cu and collagen?
GHK-Cu participates in collagen biology at multiple levels. First, it is produced endogenously when collagen is degraded — the GHK tripeptide is released from the N-terminus of the alpha-1 chain of type I collagen. This creates a biological feedback: when collagen is broken down, GHK-Cu is produced, which then stimulates new collagen synthesis and organises repair. Second, GHK-Cu delivers copper to lysyl oxidase, the enzyme that crosslinks collagen and elastin fibres, giving them mechanical strength. Third, it transcriptionally upregulates collagen genes and downregulates collagen-degrading MMPs.
Does GHK-Cu work topically or does it need to be injected?
Both routes have research data. Topical GHK-Cu penetrates the stratum corneum to some degree due to its small molecular weight (~403 Da free peptide), and topical studies show biological effects in skin. However, most mechanistic and wound healing research uses subcutaneous or systemic administration. For research purposes, route selection depends on the research question — topical for skin-specific applications, injectable for systemic tissue repair research.
Is GHK the same as GHK-Cu?
GHK is the free tripeptide (Gly-His-Lys) without copper. GHK-Cu is the copper complex. Most biological research uses GHK-Cu because the copper is integral to many of the compound’s mechanisms — particularly lysyl oxidase activation and superoxide dismutase support. The free peptide GHK has some activity but is generally considered less potent than the copper complex for most research applications.
Source GHK-Cu at FenaLife
FenaLife supplies GHK-Cu in the Cosmetic Research category with Janoshik third-party COA. Free shipping on orders over $100.
See also: GHK-Cu vs BPC-157 Comparison | Peptides in Anti-Aging Research | Peptide Storage Guide
All products sold by FenaLife are intended strictly for laboratory and academic research purposes. Not for human consumption, injection, or ingestion. These statements have not been evaluated by the FDA.
🔬 Research Compounds Referenced: GHK-Cu 100mg